The changes in stockholders’ equity for the prior year comparable period are as follows:


						Additional									Accumulated Other
	Common Stock					Paid-in			Treasury Stock						Comprehensive			Retained
	Shares			Amount		Capital			Shares			Amount			Loss			Earnings		Total
Balance at September 30, 2024		36,707,840		$	37	$	275,771			(6,015,496	)	$	(93,854	)	$	(9,427	)	$	10,033	$	182,560
Net income		—			—		—			—			—			—			5,810		5,810
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units		138,838			—		114			—			—			—			—		114
Taxes paid associated with net settlement of stock compensation awards		(30,575	)		—		(883	)		—			—			—			—		(883	)
Forfeitures of restricted stock awards		(22,500	)		—		—			—			—			—			—		—
Shares swapped to exercise stock options		—			—		19			(582	)		(19	)		—			—		—
Stock compensation expense		—			—		3,431			—			—			—			—		3,431
Foreign currency translation and other		—			—		—			—			—			(1,871	)		—		(1,871	)
Balance at December 31, 2024		36,793,603		$	37	$	278,452			(6,016,078	)	$	(93,873	)	$	(11,298	)	$	15,843	$	189,161
Net income		—			—		—			—			—			—			7,051		7,051
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units		522,121			—		78			—			—			—			—		78
Taxes paid associated with net settlement of stock compensation awards		(119,819	)		—		(3,957	)		—			—			—			—		(3,957	)
Acquisition consideration paid in common stock (Note 3)		27,260					945														945
Shares swapped to exercise stock options		—			—		28			(815	)		(28	)		—			—		—
Stock compensation expense		—			—		2,578			—			—			—			—		2,578
Foreign currency translation		—			—		—			—			—			469			—		469
Balance at March 31, 2025		37,223,165		$	37	$	278,124			(6,016,893	)	$	(93,901	)	$	(10,829	)	$	22,894	$	196,325
Net income		—			—		—			—			—			—			7,410		7,410
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units		34,554			—		—			—			—			—			—		—
Taxes paid associated with net settlement of stock compensation awards		(9,442	)		—		(266	)		—			—			—			—		(266	)
Stock compensation expense		—			—		3,512			—			—			—			—		3,512
Foreign currency translation		—			—		—			—			—			1,669			—		1,669
Balance at June 30, 2025		37,248,277		$	37	$	281,370			(6,016,893	)	$	(93,901	)	$	(9,160	)	$	30,304	$	208,650

The Company has several incentive plans under which stock options, restricted stock units (RSUs), restricted stock awards (RSAs), and cash-settled stock appreciation rights (SARs) have been issued, including the Third Amended and Restated 2006 Omnibus Long-Term Incentive Plan (as amended, the LTIP) and a plan and private placement issuances related to the Company’s acquisition of Machinio and Bid4Assets. During the nine months ended June 30, 2026, the Company's shareholders approved an amendment to the LTIP to increase the authorized number of shares of common stock under the LTIP from 22,800,000 to 25,725,000. Vesting of RSUs and grants of RSAs count as 1.5x shares against the plan reserves. As of June 30, 2026, 3,356,172 shares of common stock remained available for use.

The table below presents the components of share-based compensation expense (in thousands):


	Three Months Ended June 30,				Nine Months Ended June 30,
	2026		2025		2026		2025
Equity-classified awards:
Stock options	$	853	$	563	$	2,579	$	1,595
RSUs & RSAs		4,419		2,949		13,217		7,927
Total Equity-classified awards	$	5,272	$	3,512	$	15,796	$	9,522

The table below presents the components of share-based compensation expense by line-item within our Condensed Consolidated Statements of Operations (in thousands):


	Three Months Ended June 30,				Nine Months Ended June 30,
	2026		2025		2026		2025
Stock compensation expense by function
Technology and operations	$	826	$	581	$	2,449	$	1,559
Sales and marketing		1,602		1,142		4,935		3,016
General and administrative		2,844		1,789		8,412		4,947
Total stock compensation expense:	$	5,272	$	3,512	$	15,796	$	9,522

The stock options and RSUs & RSAs containing only service conditions will vest over a one- to four-year service period. The stock options and RSUs & RSAs containing performance conditions will vest upon the achievement of specified financial targets of the Company, a segment, or a division of a segment and vests on the first day of each fiscal quarter over one- to four-year terms of the awards, starting with the first fiscal quarter after the first anniversary of the grant date.

From time to time, we may be authorized to repurchase issued and outstanding shares of our common stock under a share repurchase program approved by our Board of Directors. Share repurchases may be made through open-market purchases, privately negotiated transactions, or otherwise, at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The repurchase program may be discontinued or suspended at any time and will be funded using our available cash.

As of September 30, 2025, the Company had $1.5 million of remaining authorization to repurchase shares through December 31, 2026. On November 17, 2025, the Company's Board of Directors authorized the repurchase of up to an additional $15.0 million of the Company's outstanding shares of common stock through December 31, 2027.

The Company made no repurchases during the three months ended June 30, 2026. The Company repurchased 56,676 shares for $1.5 million during the nine months ended June 30, 2026. As of June 30, 2026, the Company had $15.0 million of remaining authorization to repurchase shares through December 31, 2027.

Separate from the share repurchase program, our stock incentive plans allow for participants to exercise stock options by surrendering shares of common stock equivalent in value to the exercise price due. Any shares surrendered to the Company in this manner are not available for future grant.

During the nine months ended June 30, 2026, and 2025, participants surrendered 4,012 and 1,397 shares of common stock in connection with the exercise of stock options, respectively.